BAJAJ BROKING

Notification
No new Notification messages
Inventurus Knowledge Solutions IPO is Open!
Apply for the Inventurus Knowledge Solutions IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

Valiant Laboratories Ltd

Pharmaceuticals

Offer Period :

27th to 3rd Oct 2023

Valiant Laboratories, est. 1980, specializes in Paracetamol manufacturing in Palghar, Maharashtra. With an annual capacity of 9,000 MT, their R&D facility supports product development. In FY23, revenue was Rs. 3,339.10 million. Read more... The company imports raw materials from China and Cambodia. As of April 30, 2023, Valiant has 86 employees.Read less

Valiant Laboratories Ltd IPO Details

IPO Date 27th to 3rd Oct 2023 Minimum Investment ₹14700 / 1 Lots
Listing Date 2023-10-06 Maximum Investment ₹191100 / 13 Lots
Face Value ₹10 per share Total Issue Size ₹152.46 Crores
Price ₹140 to ₹140 per share Fresh Issue ₹152.46 Crores
Lot Size 1 Lots (105 Shares) Offer For Sale ₹ 0
Listing At BSE, NSE Retail Discount ₹ 0
Employee Discount ₹0 per share    
IPO Date 27th to 3rd Oct 2023
Listing Date 2023-10-06
Face Value ₹10 per share
Price ₹140 to ₹140 per share
Lot Size 1 Lots (105 Shares)
Listing At BSE, NSE
Employee Discount ₹0 per share
Minimum Investment ₹14700 / 1 Lots
Maximum Investment ₹191100 / 13 Lots
Total Issue Size ₹152.46 Crores
Fresh Issue ₹152.46 Crores
Offer For Sale
Retail Discount ₹ 0

Timeline

Important dates for allocation and IPO listing.

27th Sep

IPO Starts

3rd Oct

IPO Ends

4th Oct

Allotment Date

5th Oct

Initiation of Refund

5th Oct

Credit of Shares to Demat Account

6th Oct

IPO Listing Date

Shareholder Pattern

  Pre-Issue Post-Issue
Promoter Group 82.52 61.84
Public Group 17.48 38.16

Valiant Laboratories Ltd IPO Reservation

QIB Shares Offered 2178000(20%)
NII (HNI) Shares Offered 1633500(15%)
Retail Shares Offered 3811500(35%)
Anchor Investor Shares Offered 3267000(30%)
Total Shares Offered 10890000
Total Shares With Anchor Investor 10890000

IPO Lot Size

ApplicationLotsSharesAmount
Retail (Min)---
Retail (Max)---
S-HNI (Min)---
S-HNI (Max)---

Valiant Laboratories Ltd IPO Registrar

Link Intime India Pvt Ltd
Phone Number +91 810 811 4949
Email Id valiantlaboratories.ipo@linkintime.co.in
Our Website www.linkintime.co.in

Valiant Laboratories Ltd IPO Lead Manager

1. Unistone Capital Pvt Ltd

Explore IPOs


Explore comprehensive IPO details for every IPO. Access essential information such as listing price, listing date, issue price, lot size, issue size, minimum investment, and IPO timeline. Gain insights into the company's background, strengths, and potential risks. Track the subscription status and delve into the financials of the company, empowering yourself with crucial data for informed investment decisions. Stay ahead in the dynamic IPO market by staying informed on upcoming, ongoing, and past IPOs. 
 

Stay ahead in the ever-evolving IPO landscape with our comprehensive platform. We offer a holistic resource, ensuring you not only access essential details but also gain valuable insights into market trends. Navigate confidently, armed with intricate analyses, expert opinions, and real-time updates. Whether you're a seasoned investor or a novice, our user-friendly interface and extensive information empower you to make well-informed decisions. Experience the convenience of having a dedicated space where you can delve into the intricacies of IPOs, enabling a strategic and calculated approach to the dynamic stock market. 

Valiant Laboratories Ltd IPO Subscription LIVE Status

Category No. of shares offered No. of shares bid No. of subscribed

Strength of Valiant Laboratories Ltd

1. Experienced promoter and strong management team:

2. Strong Focus on Sustainability in Operations:

3. Strategically located manufacturing facility:

4. Quality-Focused Compliant Manufacturing and R&D Infrastructure:

5. Reducing dependence on import of raw materials:

Risks Involved

1. The company is subject to strict quality requirements, regular inspections and audits by its customers and any failure to comply with quality standards may lead to cancellation of existing and future orders and could negatively impact the company business, financial condition, results of operations and prospects it may impact the reputation as well.

2. The company does not have long-term agreements with its suppliers for raw materials and an inability to procure the desired quality, quantity of its raw materials in a timely manner and at reasonable costs, or at all, may have a negative impact on the business, results of operations, financial condition and cash flows.

3. If there are delays in setting up the Proposed Facility or if the costs of setting up and the possible time or cost overruns related to the Proposed Facility or the purchase of plant and machinery for the Proposed Facility are higher than expected, it could have a material adverse effect on its financial condition, results of operations and growth prospects.

4. The company's single product manufacturing company and any changes to the paracetamol API industry or the company product demand will adversely affect its revenues, financials and profitability.

5. The majority of its operative income is derived from the domestic market and any adverse developments in this market could adversely affect its business.

6. The company Manufacturing Facility is located in one geographic area and therefore, any localized social unrest, natural disaster or breakdown of services or any other natural disaster in and around Palghar, Maharashtra or any disruption in production at, or shutdown of, its manufacturing unit could have material adverse effect on the company business and financial condition.

7. The company is dependent on a few customers for a major part of the revenues. Further its do not enter into long-term arrangements with the customers and any failure to continue our existing arrangements could adversely affect its business and results of operations.

8. The company is in the process of expanding its operations and establishing a network of customers in a line of business where the company do not have a significant presence or prior experience. Any failure to expand into these new products could adversely affect its sales, financial condition, result of operations and cash flows.

9. The company is subject to government regulations and if its fail to obtain, maintain or renew the statutory and regulatory licenses, permits and approvals required to operate the company business, results of operations and cash flows may be adversely affected.

10. The objects of the Issue include funding working capital requirements of Valiant Advanced Sciences Private Limited, a wholly owned Subsidiary of the Company, which are based on certain assumptions and estimates.

Why should you invest in

-

Financials

Particulars For the financial year ending (in ₹ million)
  2024 2023
Total Assets 342.69 212.97
Total Liabilities 342.69 212.97
Total Expenses 192.51 300.64
Total Revenue 
191.74 338.77
Profit After Tax 0.32 29
EBITDA 1.27 39.95
Adjusted EBITDA 0 0

Valiant Laboratories Ltd IPO Listing Details

Listing Date BSE Script Code NSE Symbol ISIN Final Issue Price
2023-10-06 543998 VALIANTLAB
INE0JWS01017
₹140 per share

Listing Day Trading Information

Price Details BSE NSE
Final Issue Price ₹140 ₹140
Open ₹161 ₹162.15
Low ₹161 ₹162.1
High ₹169.05 ₹170.25
Low ₹161 ₹162.1

Frequently Asked Questions

What is Valiant Laboratories Ltd IPO?

Answer Field

Valiant Laboratories Ltd IPO is a Mainboard IPO of 1,08,90,000 equity shares of a face value of ₹10 aggregating up to ₹152.46 Crores. The issue is priced at ₹140 to ₹140 per share. The minimum order quantity is 105 Shares. The IPO opens on September 27, 2023, and closes on October 03, 2023. Link Intime India Pvt Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE,NSE.

When Valiant Laboratories Ltd IPO will open?

Answer Field

The Valiant Laboratories Ltd IPO opens on September 27, 2023 and closes on October 03, 2023.

What is the lot size of Valiant Laboratories Ltd?

Answer Field

Valiant Laboratories Ltd lot size is 105 shares, and the minimum amount required is ₹14,700.

How to apply for Valiant Laboratories Ltd IPO?

Answer Field

You can apply in Valiant Laboratories Ltd IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. To apply for an IPO:

• Login to Bajaj Broking account App/Website & click on IPO

• Enter the number of lots and price at which you wish to apply.

• Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.

• You will receive a mandate notification to block funds in your UPI app.

• Approve the mandate request on your UPI and funds will be blocked.

When is Valiant Laboratories Ltd IPO allotment?

Answer Field

The finalization of Basis of Allotment for Valiant Laboratories Ltd IPO will be done on October 04, 2023, and the allotted shares will be credited to your demat account by October 05, 2023.

When is Valiant Laboratories Ltd IPO listing date?

Answer Field

The Valiant Laboratories Ltd listing date is October 06, 2023.

Who is the registrar of Valiant Laboratories Ltd IPO?

Answer Field

The registrar of Valiant Laboratories Ltd IPO is Link Intime India Pvt Ltd

Which company is the book-running lead manager of the IPO?

Answer Field

Unistone Capital Pvt Ltd will be the book-running lead manager of this IPO.

What is the fresh issue of Valiant Laboratories Ltd IPO?

Answer Field

The fresh issue size is ₹152.46 Crores equity shares.

What minimum lot size can retail subscribers subscribe to Valiant Laboratories Ltd?

Answer Field

Retail investors can subscribe to a minimum of one lot, 105 shares and ₹14,700 amount.

How can I approve the UPI mandate request for Valiant Laboratories Ltd IPO?

Answer Field

To apply for Valiant Laboratories Ltd IPO, you need to log in to your demat account to complete the bidding process. Then, approve the payment mandate on your UPI app.

What is the price range of Valiant Laboratories Ltd?

Answer Field

The price of each Valiant Laboratories Ltd share will be ranging in between ₹140 to ₹140 per share.

What is the cut-off time for the UPI mandate for Valiant Laboratories Ltd IPO?

Answer Field

The cut-off time for the UPI mandate confirmation is 5:00 PM, October 03, 2023.

No results found

Browse IPOs

upcoming-radio
  • IPO Name
  • Bidding Dates
  • Price range
  • IPO Size
  • Lorem Ipsum
current-radio
  • IPO Name
  • Bidding Dates
  • Price range
  • IPO Size
  • Lorem Ipsum
  • YASH HIGHVOLTAGE LIMITEDSME IPO

  • Bidding Dates

    12th Dec 2024 - 12th Dec 2024

  • Price Range

    ₹138.0 - 146.0

  • IPO Size

    ₹1,10,01,00,000

  • Apply Now
  • HAMPS BIO LIMITEDSME IPO

  • Bidding Dates

    13th Dec 2024 - 12th Dec 2024

  • Price Range

    ₹51.0 - 51.0

  • IPO Size

    ₹6,22,00,000

  • Apply Now
  • NACDAC INFRASTRUCTURE LIMITEDSME IPO Early Access

  • Bidding Dates

    17th Dec 2024 - 12th Dec 2024

  • Price Range

    ₹33.0 - 35.0

  • IPO Size

    ₹10,01,00,000

  • Apply Now
  • NACDAC INFRASTRUCTURE LIMITEDSME IPO Early Access

  • Bidding Dates

    17th Dec 2024 - 12th Dec 2024

  • Price Range

    ₹33.0 - 35.0

  • IPO Size

    ₹10,01,00,000

  • Apply Now
  • IDENTICAL BRAINS STUDIOS LIMITEDSME IPO Early Access

  • Bidding Dates

    18th Dec 2024 - 12th Dec 2024

  • Price Range

    ₹51.0 - 54.0

  • IPO Size

    ₹19,95,00,000

  • Apply Now
closed-radio
  • IPO Name
  • Bidding Dates
  • Price range
  • IPO Size
  • Lorem Ipsum
  • SWIGGY LIMITEDMainboard IPO

  • Bidding Dates

    6th Nov 2024 - 11th Nov 2024

  • Price Range

    ₹371.0 - 390.0

  • IPO Size

    ₹1,13,27,43,00,000

  • Invest Now
performance-radio
  • IPO Name
  • ISSUE PRICE
  • LISTING DAY CLOSE
  • LISTING DAY(GAIN/LOSS)
  • Lorem Ipsum
  • NTPC GREEN ENERGY LIMITEDMainboard IPO

  • Issue Price

    108.00

  • Listing Day Close

    122.10

  • Listing Day (Gain/Loss)

    12.96

  • ONYX BIOTEC LIMITEDSME IPO

  • Issue Price

    61.00

  • Listing Day Close

    56.75

  • Listing Day (Gain/Loss)

    -6.56

  • ZINKA LOGISTICS SOLUTIONS LIMITEDMainboard IPO

  • Issue Price

    273.00

  • Listing Day Close

    260.20

  • Listing Day (Gain/Loss)

    -4.76

  • MANGAL COMPUSOLUTION LIMITEDSME IPO

  • Issue Price

    45.00

  • Listing Day Close

    42.75

  • Listing Day (Gain/Loss)

    -4.44

  • NEELAM LINENS AND GARMENTS INDIA LIMITEDSME IPO

  • Issue Price

    24.00

  • Listing Day Close

    38.05

  • Listing Day (Gain/Loss)

    58.33

  • NIVA BUPA HEALTH INSURANCE COMPANY LIMITEDMainboard IPO

  • Issue Price

    74.00

  • Listing Day Close

    74.00

  • Listing Day (Gain/Loss)

    0.00

  • SWIGGY LIMITEDMainboard IPO

  • Issue Price

    390.00

  • Listing Day Close

    455.95

  • Listing Day (Gain/Loss)

    16.92

  • ACME SOLAR HOLDINGS LIMITEDMainboard IPO

  • Issue Price

    289.00

  • Listing Day Close

    253.50

  • Listing Day (Gain/Loss)

    -12.11

  • SAGILITY INDIA LIMITEDMainboard IPO

  • Issue Price

    30.00

  • Listing Day Close

    29.36

  • Listing Day (Gain/Loss)

    -3.33

  • AFCONS INFRASTRUCTURE LIMITEDMainboard IPO

  • Issue Price

    463.00

  • Listing Day Close

    474.55

  • Listing Day (Gain/Loss)

    2.59

  • USHA FINANCIAL SERVICES LIMITEDSME IPO

  • Issue Price

    168.00

  • Listing Day Close

    155.85

  • Listing Day (Gain/Loss)

    -7.14

  • GODAVARI BIOREFINERIES LIMITEDMainboard IPO

  • Issue Price

    352.00

  • Listing Day Close

    342.85

  • Listing Day (Gain/Loss)

    -2.56

  • OBSC PERFECTION LIMITEDSME IPO

  • Issue Price

    100.00

  • Listing Day Close

    115.50

  • Listing Day (Gain/Loss)

    16.00

  • UNITED HEAT TRANSFER LIMITEDSME IPO

  • Issue Price

    59.00

  • Listing Day Close

    63.95

  • Listing Day (Gain/Loss)

    8.47

  • DANISH POWER LIMITEDSME IPO

  • Issue Price

    380.00

  • Listing Day Close

    598.50

  • Listing Day (Gain/Loss)

    57.63

  • WAAREE ENERGIES LIMITEDMainboard IPO

  • Issue Price

    1503.00

  • Listing Day Close

    2336.80

  • Listing Day (Gain/Loss)

    55.49

  • DEEPAK BUILDERS AND ENGINEERS INDIA LIMITEDMainboard IPO

  • Issue Price

    203.00

  • Listing Day Close

    161.90

  • Listing Day (Gain/Loss)

    -20.20

  • PREMIUM PLAST LIMITEDSME IPO

  • Issue Price

    49.00

  • Listing Day Close

    48.90

  • Listing Day (Gain/Loss)

    0.00

  • FRESHARA AGRO EXPORTS LIMITEDSME IPO

  • Issue Price

    116.00

  • Listing Day Close

    134.70

  • Listing Day (Gain/Loss)

    16.38

  • LAKSHYA POWERTECH LIMITEDSME IPO

  • Issue Price

    180.00

  • Listing Day Close

    359.10

  • Listing Day (Gain/Loss)

    99.44

We have something for everyone

Explore more Investment options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Related Articles

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs+ Users

icon-with-text

4.4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4700+ Cr MTF Book

icon-with-text